Michaela S. Banck

2.8k total citations
29 papers, 1.8k citations indexed

About

Michaela S. Banck is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michaela S. Banck has authored 29 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michaela S. Banck's work include Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (5 papers) and Cancer Treatment and Pharmacology (4 papers). Michaela S. Banck is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (5 papers) and Cancer Treatment and Pharmacology (4 papers). Michaela S. Banck collaborates with scholars based in United States, Germany and Spain. Michaela S. Banck's co-authors include Andreas S. Beutler, Martin J. Walsh, Rahul Kanwar, Goutham Narla, Scott L. Friedman, Amit Kulkarni, Gary P. Schroth, SiDe Li, Marc Rodríguez‐Niedenführ and Goedele N. Maertens and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Michaela S. Banck

29 papers receiving 1.8k citations

Peers

Michaela S. Banck
Seema S. Deshpande United States
Michael Majores Germany
Spiegel Am United States
Laura Harrington United Kingdom
József L. Varga United States
Xiaozhong Qian United States
Minggui Pan United States
Knut Dietzmann Germany
Joan‐Marc Servitja Spain
Bendi Gong United States
Seema S. Deshpande United States
Michaela S. Banck
Citations per year, relative to Michaela S. Banck Michaela S. Banck (= 1×) peers Seema S. Deshpande

Countries citing papers authored by Michaela S. Banck

Since Specialization
Citations

This map shows the geographic impact of Michaela S. Banck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela S. Banck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela S. Banck more than expected).

Fields of papers citing papers by Michaela S. Banck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela S. Banck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela S. Banck. The network helps show where Michaela S. Banck may publish in the future.

Co-authorship network of co-authors of Michaela S. Banck

This figure shows the co-authorship network connecting the top 25 collaborators of Michaela S. Banck. A scholar is included among the top collaborators of Michaela S. Banck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaela S. Banck. Michaela S. Banck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Le‐Rademacher, Jennifer, Camden Lopez, Rahul Kanwar, et al.. (2020). Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-tooth disease genes. Journal of the Neurological Sciences. 411. 116687–116687. 3 indexed citations
2.
Le‐Rademacher, Jennifer, Rahul Kanwar, Drew K. Seisler, et al.. (2017). Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials. Supportive Care in Cancer. 25(11). 3537–3544. 56 indexed citations
3.
Rosen, Lee S., Jonathan W. Goldman, Alain P. Algazi, et al.. (2016). A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer. Clinical Cancer Research. 23(8). 1910–1919. 57 indexed citations
4.
Kanwar, Rahul, Regenia L. Smalley, Julie M. Cunningham, et al.. (2015). Plasticity of DNA methylation in a nerve injury model of pain. Epigenetics. 10(3). 200–212. 28 indexed citations
5.
Kulkarni, Amit, Rahul Kanwar, Peter Beyerlein, et al.. (2015). Association of the Charcot–Marie–Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance). Journal of the Neurological Sciences. 357(1-2). 35–40. 39 indexed citations
6.
Kanwar, Rahul, Amit Kulkarni, Matthew M. Ames, et al.. (2015). Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines. Cancer Genetics. 208(7-8). 374–381. 67 indexed citations
7.
Banck, Michaela S. & Andreas S. Beutler. (2014). Advances in small bowel neuroendocrine neoplasia. Current Opinion in Gastroenterology. 30(2). 163–167. 8 indexed citations
8.
Banck, Michaela S., Rahul Kanwar, Amit Kulkarni, et al.. (2013). The genomic landscape of small intestine neuroendocrine tumors. Journal of Clinical Investigation. 123(6). 2502–2508. 208 indexed citations
9.
Zhang, Lu, Rahul Kanwar, Irina Khrebtukova, et al.. (2012). Diametrically opposite methylome-transcriptome relationships in high- and low-CpG promoter genes in postmitotic neural rat tissue. Epigenetics. 7(5). 421–428. 30 indexed citations
10.
Banck, Michaela S., et al.. (2010). p53-Induced Growth Arrest Is Regulated by the Mitochondrial SirT3 Deacetylase. PLoS ONE. 5(5). e10486–e10486. 131 indexed citations
11.
Banck, Michaela S., Shujun Luo, Irina Khrebtukova, et al.. (2010). mRNA-seq with agnostic splice site discovery for nervous system transcriptomics tested in chronic pain. Genome Research. 20(6). 847–860. 59 indexed citations
12.
Banck, Michaela S., SiDe Li, Hitomi Nishio, et al.. (2009). The ZNF217 oncogene is a candidate organizer of repressive histone modifiers. Epigenetics. 4(2). 100–106. 62 indexed citations
13.
Barradas, Marta, Emma Anderton, Juan Carlos Acosta, et al.. (2009). Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes & Development. 23(10). 1177–1182. 271 indexed citations
14.
Storek, Benjamin, Cheng Wang, William G.M. Janssen, et al.. (2008). Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain. Proceedings of the National Academy of Sciences. 105(3). 1055–1060. 102 indexed citations
15.
Narla, Goutham, Ying‐Bei Chen, Eldad A. Hod, et al.. (2006). Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. Journal of Hepatology. 46(4). 645–654. 71 indexed citations
16.
Banck, Michaela S., Simon W. Beaven, Goutham Narla, et al.. (2006). KLF6 degradation after apoptotic DNA damage. FEBS Letters. 580(30). 6981–6986. 27 indexed citations
17.
Li, Dan, Steven Yea, SiDe Li, et al.. (2005). Krüppel-like Factor-6 Promotes Preadipocyte Differentiation through Histone Deacetylase 3-dependent Repression of DLK1. Journal of Biological Chemistry. 280(29). 26941–26952. 144 indexed citations
18.
Benzeno, Sharon, Goutham Narla, Jorge Allina, et al.. (2004). Cyclin-Dependent Kinase Inhibition by the KLF6 Tumor Suppressor Protein through Interaction with Cyclin D1. Cancer Research. 64(11). 3885–3891. 125 indexed citations
19.
Beutler, Andreas S., Michaela S. Banck, Dirk Wedekind, & Hans J. Hedrich. (1999). Tumor Gene Therapy Made Easy: Allogeneic Major Histocompatibility Complex in the C6 Rat Glioma Model. Human Gene Therapy. 10(1). 95–101. 51 indexed citations
20.
Beutler, Andreas S., Michaela S. Banck, Flemming W. Bach, et al.. (1995). Retrovirus‐Mediated Expression of an Artificial β‐Endorphin Precursor in Primary Fibroblasts. Journal of Neurochemistry. 64(2). 475–481. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seema S. Deshpande Breakdown of academic impact, for papers by Michael Majores Breakdown of academic impact, for papers by Spiegel Am Breakdown of academic impact, for papers by Laura Harrington Breakdown of academic impact, for papers by József L. Varga Breakdown of academic impact, for papers by Xiaozhong Qian Breakdown of academic impact, for papers by Minggui Pan Breakdown of academic impact, for papers by Knut Dietzmann Breakdown of academic impact, for papers by Joan‐Marc Servitja Breakdown of academic impact, for papers by Bendi Gong
Rankless by CCL
2026